Design, recombinant expression and convenient A-chain N-terminal europium-labelling of a fully active human relaxin-3 analogue

FEBS Journal

Volumn 279, Issue 8, 2012, Pages 1505-1512

  Zhang, Wei Jie ^a   Luo, Xiao ^a   Song, Ge ^a   Wang, Xin Yi ^a   Shao, Xiao Xia ^a   Guo, Zhan Yun ^a  

^a TONGJI UNIVERSITY   (China)

Author keywords

INSL7; insulin like peptide; labelling; receptor; relaxin 3

Indexed keywords

EUROPIUM; G PROTEIN COUPLED RECEPTOR; PROTEIN RXFP3; RECOMBINANT PROTEIN; RELAXIN 3; TETRAXETAN; UNCLASSIFIED DRUG;

ALPHA CHAIN; AMINO TERMINAL SEQUENCE; ARTICLE; BINDING AFFINITY; CONTROLLED STUDY; EMBRYO; HUMAN; HUMAN CELL; ISOTOPE LABELING; PRIORITY JOURNAL; PROTEIN EXPRESSION;

AMINO ACID SEQUENCE; BINDING, COMPETITIVE; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CIRCULAR DICHROISM; DRUG DESIGN; EUROPIUM; HETEROCYCLIC COMPOUNDS, 1-RING; HUMANS; MOLECULAR SEQUENCE DATA; PROTEIN FOLDING; RECEPTORS, G-PROTEIN-COUPLED; RECOMBINANT PROTEINS; RELAXIN; RESEARCH DESIGN;

EID: 84862783322     PISSN: 1742464X     EISSN: 17424658     Source Type: Journal    
DOI: 10.1111/j.1742-4658.2012.08550.x     Document Type: Article

References (30)

1. Shabanpoor F, Separovic F, &, Wade JD, (2009) The human insulin superfamily of polypeptide hormones. Vitam Horm 80, 1-31.
2. Smith CM, Ryan PJ, Hosken IT, Ma S, &, Gundlach AL, (2011) Relaxin-3 systems in the brain-the first 10 years. J Chem Neuroanat 42, 262-275.
3. Tanaka M, (2010) Relaxin-3/insulin-like peptide 7, a neuropeptide involved in the stress response and food intake. FEBS J 277, 4990-4997.
4. Bathgate RA, Samuel CS, Burazin TC, Layfield S, Claasz AA, Reytomas IG, Dawson NF, Zhao C, Bond C, Summers RJ, et al. (2002) Human relaxin gene 3 (H3) and the equivalent mouse relaxin (M3) gene: novel members of the relaxin peptide family. J Biol Chem 277, 1148-1157.
5. Ryan PJ, Ma S, Olucha-Bordonau FE, &, Gundlach AL, (2011) Nucleus incertus-an emerging modulatory role in arousal, stress and memory. Neurosci Biobehav Rev 35, 1326-1341.
6. Burazin TC, Bathgate RA, Macris M, Layfield S, Gundlach AL, &, Tregear GW, (2002) Restricted, but abundant, expression of the novel rat gene-3 (R3) relaxin in the dorsal tegmental region of brain. J Neurochem 82, 1553-1557.
7. Silvertown JD, Neschadim A, Liu HN, Shannon P, Walia JS, Kao JC, Robertson J, Summerlee AJ, &, Medin JA, (2010) Relaxin-3 and receptors in the human and rhesus brain and reproductive tissues. Regul Pept 159, 44-53.
8. Ma S, Sang Q, Lanciego JL, &, Gundlach AL, (2009) Localization of relaxin-3 in brain of Macaca fascicularis: identification of a nucleus incertus in primate. J Comp Neurol 517, 856-872.
9. Tanaka M, Iijima N, Miyamoto Y, Fukusumi S, Itoh Y, Ozawa H, &, Ibata Y, (2005) Neurons expressing relaxin 3/INSL 7 in the nucleus incertus respond to stress. Eur J Neurosci 21, 1659-1670.
10. Smith CM, Shen PJ, Banerjee A, Bonaventure P, Ma S, Bathgate RA, Sutton SW, &, Gundlach AL, (2010) Distribution of relaxin-3 and RXFP3 within arousal, stress, affective, and cognitive circuits of mouse brain. J Comp Neurol 518, 4016-4045.
11. Olucha-Bordonau FE, Otero-García M, Sánchez-Pérez AM, Núñez A, Ma S, &, Gundlach AL, (2011) Distribution and targets of the relaxin-3 innervation of the septal area in the rat. J Comp Neurol, doi:.
12. Watanabe Y, Miyamoto Y, Matsuda T, &, Tanaka M, (2011) Relaxin-3/INSL7 regulates the stress-response system in the rat hypothalamus. J Mol Neurosci 43, 169-174.
13. Banerjee A, Shen PJ, Ma S, Bathgate RA, &, Gundlach AL, (2010) Swim stress excitation of nucleus incertus and rapid induction of relaxin-3 expression via CRF1 activation. Neuropharmacology 58, 145-155.
14. McGowan BM, Stanley SA, Smith KL, White NE, Connolly MM, Thompson EL, Gardiner JV, Murphy KG, Ghatei MA, &, Bloom SR, (2005) Central relaxin-3 administration causes hyperphagia in male Wistar rats. Endocrinology 146, 3295-3300.
15. McGowan BM, Stanley SA, Smith KL, Minnion JS, Donovan J, Thompson EL, Patterson M, Connolly MM, Abbott CR, Small CJ, et al. (2006) Effects of acute and chronic relaxin-3 on food intake and energy expenditure in rats. Regul Pept 136, 72-77.
16. Hida T, Takahashi E, Shikata K, Hirohashi T, Sawai T, Seiki T, Tanaka H, Kawai T, Ito O, Arai T, et al. (2006) Chronic intracerebroventricular administration of relaxin-3 increases body weight in rats. J Recept Signal Transduct Res 26, 147-158.
17. McGowan BM, Stanley SA, White NE, Spangeus A, Patterson M, Thompson EL, Smith KL, Donovan J, Gardiner JV, Ghatei MA, et al. (2007) Hypothalamic mapping of orexigenic action and Fos-like immunoreactivity following relaxin-3 administration in male Wistar rats. Am J Physiol Endocrinol Metab 292, E913-E919.
18. McGowan BM, Stanley SA, Donovan J, Thompson EL, Patterson M, Semjonous NM, Gardiner JV, Murphy KG, Ghatei MA, &, Bloom SR, (2008) Relaxin-3 stimulates the hypothalamic-pituitary-gonadal axis. Am J Physiol Endocrinol Metab 295, E278-E286.
19. Smith CM, Hosken IT, Sutton SW, Lawrence AJ, &, Gundlach AL, (2012) Relaxin-3 null mutation mice display a circadian hypoactivity phenotype. Genes Brain Behav 11, 94-104.
20. Watanabe Y, Tsujimura A, Takao K, Nishi K, Ito Y, Yasuhara Y, Nakatomi Y, Yokoyama C, Fukui K, Miyakawa T, et al. (2011) Relaxin-3-deficient mice showed slight alteration in anxiety-related behavior. Front Behav Neurosci 5, 50.
21. Smith CM, Lawrence AJ, Sutton SW, &, Gundlach AL, (2009) Behavioral phenotyping of mixed background (129S5:B6) relaxin-3 knockout mice. Ann N Y Acad Sci 1160, 236-241.
22. Smith CM, Shen PJ, Ma S, Sutton SW, &, Gundlach AL, (2009) Verification of a relaxin-3 knockout/LacZ reporter mouse as a model of relaxin-3 deficiency. Ann N Y Acad Sci 1160, 259-260.
23. Liu C, Eriste E, Sutton S, Chen J, Roland B, Kuei C, Farmer N, Jörnvall H, Sillard R, &, Lovenberg TW, (2003) Identification of relaxin-3/INSL7 as an endogenous ligand for the orphan G-protein-coupled receptor GPCR135. J Biol Chem 278, 50754-50764.
24. Zhang WJ, Luo X, Liu YL, Shao XX, Wade JD, Bathgate RA, &, Guo ZY, (2012) Site-specific DOTA/europium-labeling of recombinant human relaxin-3 for receptor-ligand interaction studies. Amino Acids, doi:-z
25. Luo X, Liu YL, Layfield S, Shao XX, Bathgate RA, Wade JD, &, Guo ZY, (2010) A simple approach for the preparation of mature human relaxin-3. Peptides 31, 2083-2088.
26. Luo X, Bathgate RA, Zhang WJ, Liu YL, Shao XX, Wade JD, &, Guo ZY, (2010) Design and recombinant expression of insulin-like peptide 5 precursors and the preparation of mature human INSL5. Amino Acids 39, 1343-1352.
27. Luo X, Bathgate RA, Liu YL, Shao XX, Wade JD, &, Guo ZY, (2009) Recombinant expression of an insulin-like peptide 3 (INSL3) precursor and its enzymatic conversion to mature human INSL3. FEBS J 276, 5203-5211.
28. Rosengren KJ, Lin F, Bathgate RA, Tregear GW, Daly NL, Wade JD, &, Craik DJ, (2006) Solution structure and novel insights into the determinants of the receptor specificity of human relaxin-3. J Biol Chem 281, 5845-5851.
29. Zhu J, Kuei C, Sutton S, Kamme F, Yu J, Bonaventure P, Atack J, Lovenberg TW, &, Liu C, (2008) Identification of the domains in RXFP4 (GPCR142) responsible for the high affinity binding and agonistic activity of INSL5 at RXFP4 compared to RXFP3 (GPCR135). Eur J Pharmacol 590, 43-52.
30. Zerhouni S, Amrani A, Nijs M, Smolders N, Azarkan M, Vincentelli J, &, Looze Y, (1998) Purification and characterization of papaya glutamine cyclotransferase, a plant enzyme highly resistant to chemical, acid and thermal denaturation. Biochim Biophys Acta 1387, 275-290.